Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2012
11/21/2012CN102205102B Chinese medical plantar pain-relieving ointment for treating plantar fasciitis
11/21/2012CN102153672B Method for extracting chondroitin sulfate
11/21/2012CN102144958B Notoginsenoside-containing medicinal toothpaste and preparation method thereof
11/21/2012CN102138900B Solid preparation of oxapium iodide liposome
11/21/2012CN102091289B Traditional Chinese medicine preparation for treating acute and chronic soft tissue injuries
11/21/2012CN102091111B Saussurea cataplasm and production method thereof
11/21/2012CN102008474B Application of nitidine chloride to preparation of medicament for treating autoimmune disease and graft rejection disease
11/21/2012CN102008468B Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases
11/21/2012CN101973957B 5-benzylidene-2,4-thiazolidinedione derivatives and preparation method and application thereof
11/21/2012CN101933962B Ligusticum wallichii formulation granule and preparation method thereof
11/21/2012CN101327010B Method for preparing amber ginseng
11/21/2012CN101137382B Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
11/21/2012CN101128452B Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same
11/20/2012US8314109 6-heterocyclic-imidazo[1,2-α]pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
11/20/2012US8314081 Bisphosphonate compounds
11/20/2012US8314074 Formulations comprising antisense nucleotides to connexins
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8313913 Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa
11/20/2012US8313768 Manufacture of tablet having immediate release region and sustained release region
11/20/2012CA2710054C Oil extract from a bivalve mollusc that is rich in n-acylethanolamides
11/20/2012CA2634811C Novel modifications to 2-amino-4-(4-fluorobenzylamino) -1- ethoxycarbonyl-aminobenzene and processes for preparing said compound
11/20/2012CA2584406C Lecithinized superoxide dismutase composition and a process for its production
11/20/2012CA2492989C Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
11/20/2012CA2482466C Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
11/20/2012CA2335362C Use of a dipeptide for stimulating repair processes
11/15/2012WO2012155055A2 Integrin-targeted imaging of inflammation in vascular remodeling
11/15/2012WO2012154944A2 Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits
11/15/2012WO2012154885A2 Carbonic anhydrase targeting agents and methods of using same
11/15/2012WO2012154474A2 Biomaterial composite composition and method of use
11/15/2012WO2012154274A1 Triazolopyridine compounds as pim kinase inhibitors
11/15/2012WO2012153854A1 Cytokine-chemokine modulator
11/15/2012WO2012153832A1 Composition for external skin use for inflammatory diseases
11/15/2012WO2012153827A1 Stable drug composition
11/15/2012WO2012153729A1 Heteroaromatic ring derivative
11/15/2012WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant
11/15/2012WO2012153396A1 Non-aqueous patch
11/15/2012WO2012152940A2 Small molecule inhibitors of trpa1
11/15/2012WO2012152709A1 Hydrophobic preparations
11/15/2012WO2011106729A3 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
11/15/2012US20120289614 Functionalized biodegradable triclosan monomers and oligomers for controlled release
11/15/2012US20120289609 Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
11/15/2012US20120289600 Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289582 Methods for diagnosing and treating a pathology associated with a synonymous mutation occuring within a gene of interest
11/15/2012US20120289578 Use of rna interference for treating or reducing pain
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120289549 New hexahydropyrroloimidazolone compounds
11/15/2012US20120289541 Methods and compositions for applying moxifloxacin to the ear
11/15/2012US20120289540 Kinase inhibitors useful for the treatment of proliferative diseases
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289534 Package for improved treatment of conditions
11/15/2012US20120289528 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
11/15/2012US20120289518 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/15/2012US20120289513 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
11/15/2012US20120289498 Compositions And Methods Relating To Novel Compounds And Targets Thereof
11/15/2012US20120289496 Novel compounds as modulators of protein kinases
11/15/2012US20120289490 Compositions and methods for enhancing corticosteroid delivery
11/15/2012US20120289488 Steroid-Sparing Effects of Beta-Adrenergic Inverse Agonists and Uses Thereof
11/15/2012US20120289484 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
11/15/2012US20120289473 Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water-soluble extract from plant of solanum genus
11/15/2012US20120289471 Novel compounds with high therapeutic index
11/15/2012US20120289470 Transmucosal administration of drug compositions for treating and preventing disorders in animals
11/15/2012US20120289452 Compositions and methods for treating and preventing necrosis
11/15/2012US20120288571 Antimicrobial Agents and Methods of Use
11/15/2012US20120288568 Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (rbp), and/or serum retinol-rbp modulation
11/15/2012US20120288567 Opioid Agonist Formulations with Releasable And Sequestered Antagonist
11/15/2012US20120288562 Acid Resistant Capsules
11/15/2012US20120288559 Organic compounds
11/15/2012US20120288557 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
11/15/2012US20120288555 Antiproliferative compositions comprising curcumin analogs and methods of producing and using same
11/15/2012US20120288534 Corticosteroids for the Treatment of Joint Pain
11/15/2012US20120288532 Multi-layered, multiple unit pharmaceutical compositions
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/15/2012US20120288494 Anti-IL-12/IL-23 antibodies and uses thereof
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120288487 Biodegradable paox polymer particle with cationic property
11/15/2012US20120288474 Composition for treatment of cxcl8-mediated lung inflammation
11/15/2012CA2835595A1 Non-aqueous patch
11/15/2012CA2835330A1 Sustained release paracetamol formulations
11/15/2012CA2835286A1 Carbonic anhydrase targeting agents and methods of using same
11/15/2012CA2835191A1 Hydrophobic preparations
11/15/2012CA2834828A1 Small molecule inhibitors of trpa1
11/15/2012CA2828269A1 Triazolopyridine compounds as pim kinase inhibitors
11/14/2012EP2522659A2 Modulators of ATP-binding cassette transporters
11/14/2012EP2522344A1 Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
11/14/2012EP2522343A1 Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
11/14/2012EP2521782A1 Flt3 receptor antagonists for the treatment or the prevention of pain disorders
11/14/2012EP2521714A1 Sulfone compounds as 5-ht6 receptor ligands
11/14/2012EP2521713A2 Dp2 antagonist and uses thereof
11/14/2012EP2521548A2 Quinazolin-4(3a)-one derivatives and methods of use thereof
11/14/2012EP2521544A2 Topical transdermal dexmedetomidine compositions and methods of use thereof
11/14/2012EP2521454A1 Treatment with vb-201
11/14/2012EP2521447A1 Fatty acid fumarate derivatives and their uses
11/14/2012CN202526620U Plaster with health care recovery function
11/14/2012CN102781898A GPBP inhibition using Q2 peptidomimetics
11/14/2012CN102781473A Pharmaceutical composition for external use
11/14/2012CN102781472A Radiation therapy agent
11/14/2012CN102781445A Sigma ligands for use in the prevention and/or treatment of postoperative pain
11/14/2012CN102781258A Nutritional compositions for modulating inflammation including exogenous vitamin K2
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 1272